Epson America, Inc. today announced that Millstone Medical Outsourcing, a Massachusetts-based provider of medical packaging outsourcing solutions, has selected the Epson ColorWorks® C7500G inkjet label printer to create high-quality color and black-and-white packaging labels for its growing roster of orthopedic and spine customers. As a leading provider of packaging and distribution services, including advanced inspection and validation of medical and clean room device packaging and re-packaging, Millstone Medical Outsourcing required a high-quality label printing solution to address the varying demands of its customers, and the Epson ColorWorks C7500G provided a flexible and easy-to-use option to meet their needs.
“Our customers demand durable, high-quality label and packaging solutions with sometimes very specific details such as barcodes, graphics and meticulous logos – expectations that laser printers, and even legacy two-step inkjet color printing solutions, just couldn’t meet,” said Michael Morrissette, program manager, Millstone Medical Outsourcing. “Using the Epson ColorWorks solution to print on-demand, full color labels has allowed us to better manage our expenses and keep up with the ever-changing medical packaging market. The Epson printer is a product that we can rely on to get the job done for our clients.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7820752-epson-millstone-medical-case-study/
As school dismisses for the summer, students of all ages look forward to the carefree days of summertime, but many kids experience what is called the “summer slide.” Studies show that kids can lose up to two months of learning. Kumon, the world’s largest after-school math and reading program, is offering free registration at participating learning centers from June 1-30 to help students continue learning through the summer months.
While a break from the mental taxation of school is needed, challenging children year round is the key to having a strong start the following school year.
“Students can avoid summer learning loss by keeping their minds active and absorbing new knowledge,” said Dominique Ciccarelli, Ed. M., education specialist for Kumon North America. “Continuous study throughout the summer helps ease students into the new school year with sharper skills and enables them to tackle new challenges.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7720257-kumon-free-registration/
Abila, the leading provider of software and services to nonprofits, associations, and government entities, today announced findings from its Donor Loyalty Study: A Deep Dive into Donor Behaviors and Attitudes. The study is an extension of Abila’s Donor Engagement Study from 2015, and provides a much more detailed look at specific attitudes and behaviors of donors; type, length, and frequency of content that resonates with donors; the importance of personalization; and how donors view the use of donated dollars.
The study also includes insights across four generations (Millennials, Generation Xers, Boomers, and Matures), as well as a special section on high-wealth donors (those who make more than $200,000 annually).
To view the multimedia release go to:
http://www.multivu.com/players/English/7802151-abila-donor-loyalty-study/
PDI, a leader in infection prevention products and solutions, announced the launch of its new EASY SCREEN™ CLEANING WIPE. This new product addresses the increasing use of touchscreen equipment in healthcare and the need for compatible cleaning products.
According to the Epocrates 2014 Mobile Trends Report, the presence of “digital omnivores,” a clinician regularly using digital devices including tablets, smartphones and computers, was 41 percent in 2014 and was predicted to increase to 74 percent in 2015. One of the biggest surges was expected to come from tablet usage, going from 45 percent in 2014 to 80 percent in 2015. Withstanding the apparent increase in touchscreen device usage in healthcare, a June 2015 study in the American Journal of Infection Control stated that proper protocols are lacking to address sensitive surfaces like touchscreen devices.
“Healthcare facilities are advancing everyday and it’s vital that we, as infection prevention leaders, are aware of the changes that are happening and able to adapt quickly. We created the EASY SCREEN™ CLEANING WIPE in response to the increasing usage of touchscreens and the need for a compatible product that wouldn’t damage the technology,” said PDI Senior Product Manager, Melanie Waddell.
To view the multimedia release go to:
http://www.multivu.com/players/English/7782451-pdi-easy-screen-cleaning-wipe/
More than 15 percent of reproductive-aged women have filled a prescription for an antidepressant medication during the years 2008–2013, according to a new analysis published today in the Centers for Disease Control and Prevention (CDC)’s Morbidity and Mortality Weekly Report (MMWR).
January is National Birth Defects Prevention Month and the CDC is working with the March of Dimes to raise awareness about the use of antidepressant medications by women of reproductive age, and what women should know and do for their own health and that of their babies. There is conflicting evidence about the potential link between some antidepressants and certain birth defects. Some commonly used antidepressants are sertraline (Zoloft), bupropion (Wellbutrin, Zyban), and citalopram (Celexa).
To view the multimedia release go to:
http://www.multivu.com/players/English/7709851-march-of-dimes-antidepressant-pregnancy-study/
“Want to enjoy life,” “like to learn things,” “look for adventures and like to take risks” – these traits tell the story of how Americans perceive entrepreneurs, as revealed in the 2015 Amway Global Entrepreneurship Report (AGER).
It’s an optimism that permeates the research again this year, with 86 percent of Americans expressing positive attitudes toward entrepreneurship, up a remarkable 24 percent from 2014 and a resounding 11 percent more than the 2015 global average (75 percent). Echoed by their strong desire for “independence from an employer” and “self-fulfillment, possibility to realize own ideas,” at 75 percent and 72 percent respectively, this positivity is indicative of the country’s thriving entrepreneurial spirit.
“The attitude toward entrepreneurship is not only remarkably high but significantly increased from last year when fewer than two-thirds of respondents reported a positive attitude,” notes Dr. David B. Audretsch, professor and director of the Institute for Development Strategies at the Indiana University School of Public and Environmental Affairs. “What’s more, the secondary importance of financial compensation contradicts the most prevalent stereotypes and myths about why people choose entrepreneurship.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7402451-amway-ager-spirit-index/
International research led by University College London (UCL) as part of the ‘Cities Changing Diabetes’ partnership programme challenges current scientific understanding of the rapid rise of diabetes in cities. The findings suggest that in cities around the world, social and cultural factors play a far more important role in the spread of the epidemic than previously thought.
More than two thirds of the world’s 400 million people with diabetes live in urban areas.1,2 The year-long study for Cities Changing Diabetes, a unique public-private-academic partnership, sought to better understand what makes people vulnerable to type 2 diabetes in cities in order to inform solutions for one of the most pressing modern-day public health challenges. To explore this complex issue, more than 550 interviews were undertaken with at-risk and diagnosed people in five major cities – Copenhagen, Houston, Mexico City, Shanghai and Tianjin.
“By largely focusing on biomedical risk factors for diabetes, traditional research has not adequately accounted for the impact of social and cultural drivers of disease,” says David Napier, Professor of Medical Anthropology, UCL. “Our pioneering research will enable cities worldwide to help populations adapt to lifestyles that make them less vulnerable to diabetes.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7690951-study-rethink-rise-diabetes-in-cities/
As sleaze oozes from the Pentagon,
banished Marine and Naval Academy alum Susanna Marcasi finds a web of
corruption and must take on a man to whom all are beholden, Defense
Secretary Manfred Stahl. Can she bring down the cloistered power
brokers deep within the military’s superstructure and survive? Blood
Stripe: The Susanna Marcasi Chronicles. Find out more at:
http://www.GinaMariaDiNicolo.com or on Amazon at:
http://j.mp/Blood-Stripe Cincinnati City Beat and
Amazon reviewer John Kelly says “Like a literary version of ‘A Few Good
Men (and Women)’ on steroids, Gina Maria DiNicolo rips into your
emotional core like a ‘kill shot’ from page one and never lets up for
322 pages. This book, not for the weak of heart, tells the story of
strength, courage and no mercy in the most elite units of the U.S.
Armed Forces.” Baltimore native Gina Maria DiNicolo graduated
from the U.S. Naval Academy with a degree in history and an attraction
to the unconventional. She accepted a commission in the U.S. Marine
Corps where she worked in aviation, recruiting, history, and public
affairs. As a fulltime author and historian, in addition to her two
books, DiNicolo has written scores of articles for the Military Officer
Magazine and other publications. After publishing Blood Stripe, she
sought to get her historian game on and accepted a one-year, work/study
assignment as a senior editor for the U.S. Army Center of Military
History in Washington, D.C., producing studies on military operations
in Iraq and Afghanistan. She is a dancer specializing in Argentine
Tango. For a review copy of Blood Stripe: The Susanna
Marcasi Chronicles or to arrange an interview with Gina Maria
DiNicolo contact Scott Lorenz of Westwind Communications Book
Marketing http://www.book-marketing-expert.com/ or by phone
734-667-2090.
Today, Cox Enterprises released the results of the second annual Cox Conserves Sustainability Survey, which showcased that Millennials will lead the way for small and medium businesses in future conversations and efforts around conservation, energy efficiency and environmental stewardship. The survey, commissioned by Cox Enterprises, is a national study that examines sustainability opportunities and challenges for small and medium-sized businesses (SMBs).
The top finding from the 2015 survey is that Millennials have a huge appetite for sustainability and will drive adoption of these practices. Millennials showed greater knowledge about sustainability than other age cohorts and a strong interest in implementing sustainable business practices, but noted that in their current roles, they lacked the influence needed to effect change.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7486651-cox-conserves-sustainability-survey/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
